Leah M. Lozier, BS; Elise M. Cardinale, BA; John W. VanMeter, PhD; et al.
free access
JAMA Psychiatry. 2014;71(6):627-636. doi:10.1001/jamapsychiatry.2013.4540
Lozier and colleagues assessed the unique neurobiological covariates of callous-unemotional traits and externalizing behaviors in youths with conduct problems and determined whether neural dysfunction linked to callous-unemotional traits mediates the link between callousness and proactive aggression.
Daniel Umbricht, MD; Daniela Alberati, PhD; Meret Martin-Facklam, PhD; et al.
free access
JAMA Psychiatry. 2014;71(6):637-646. doi:10.1001/jamapsychiatry.2014.163
Umbricht and colleagues aimed to determine the efficacy and safety of bitopertin, a glycine reuptake inhibitor, in patients with schizophrenia and predominant negative symptoms who were stable while taking an antipsychotic treatment. Goff provided a related .
-
Editorial
Bitopertin: The Good News and Bad News
Donald C. Goff, MD
JAMA Psychiatry
Dwight Dickinson, PhD; Richard E. Straub, PhD; Joey W. Trampush, PhD; et al.
free access
JAMA Psychiatry. 2014;71(6):647-656. doi:10.1001/jamapsychiatry.2014.157
Dickinson and colleagues aimed to identify single-nucleotide polymorphisms associated with general cognitive ability in people with schizophrenia and control individuals.
Meta-analysis
John I. Nurnberger Jr, MD, PhD; Daniel L. Koller, PhD; Jeesun Jung, PhD; et al.
free access
JAMA Psychiatry. 2014;71(6):657-664. doi:10.1001/jamapsychiatry.2014.176
Nurnberger et al identify biological pathways that contribute to risk for bipolar disorder using genes with consistent evidence for association in multiple genome-wide association studies.
Suzanne Goh, MD; Zhengchao Dong, PhD; Yudong Zhang, PhD; et al.
free access
JAMA Psychiatry. 2014;71(6):665-671. doi:10.1001/jamapsychiatry.2014.179
Goh and colleagues assess brain lactate in individuals with autism spectrum disorder and typically developing controls using high-resolution, multiplanar spectroscopic imaging, and map the distribution of lactate in the brains of individuals with autism spectrum disorder, assessing correlations of elevated brain lactate with age, autism subtype, and intellectual ability.
Ceren Akdeniz, MSc; Heike Tost, MD, PhD; Fabian Streit, MSc; et al.
free access
JAMA Psychiatry. 2014;71(6):672-680. doi:10.1001/jamapsychiatry.2014.35
Akdeniz et al study neural social stress processing, using functional magnetic resonance imaging, and associations with perceived discrimination in ethnic minority individuals. Wager and Gianaros provide commentary in a related editorial.
-
Editorial
The Social Brain, Stress, and Psychopathology
Tor D. Wager, PhD; Peter J. Gianaros, PhD
JAMA Psychiatry
Adriana Feder, MD; Michael K. Parides, PhD; James W. Murrough, MD; et al.
free access
JAMA Psychiatry. 2014;71(6):681-688. doi:10.1001/jamapsychiatry.2014.62
In a proof-of-concept, randomized, double-blind, crossover trial comparing ketamine with an active placebo control, midazolam, conducted at a single site, Feder and coauthors test the efficacy and safety of a single intravenous subanesthetic dose of ketamine for the treatment of posttraumatic stress disorder (PTSD) and associated depressive symptoms in patients with chronic PTSD.
Jennifer Freeman, PhD; Jeffrey Sapyta, PhD; Abbe Garcia, PhD; et al.
free access
JAMA Psychiatry. 2014;71(6):689-698. doi:10.1001/jamapsychiatry.2014.170
In a 14-week randomized clinical trial, Freeman and coauthors examine the relative efficacy of family-based cognitive behavior therapy involving exposure plus response prevention vs a family-based relaxation treatment control condition for children 5 to 8 years of age.
Dominique F. Maciejewski, BSc; Hanneke E. Creemers, PhD; Michael T. Lynskey, PhD; et al.
free access
JAMA Psychiatry. 2014;71(6):699-705. doi:10.1001/jamapsychiatry.2014.89
Maciejewski et al determine the relative importance of genetic and environmental influences on the variation in nonsuicidal self-injury and suicidal ideation and their covariation.